Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Hype or hope - Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?
Crit Rev Oncol Hematol. 2021 Oct;166:103454. doi: 10.1016/j.critrevonc.2021.103454. Epub 2021 Aug 26.
Crit Rev Oncol Hematol. 2021.
PMID: 34455092
Free article.
Review.
Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs.
Leonetti A, Capula M, Minari R, Mazzaschi G, Gregori A, El Hassouni B, Papini F, Bordi P, Verzè M, Avan A, Tiseo M, Giovannetti E.
Leonetti A, et al. Among authors: papini f.
Cells. 2021 Jun 16;10(6):1520. doi: 10.3390/cells10061520.
Cells. 2021.
PMID: 34208765
Free PMC article.
Item in Clipboard
"Open Sesame?": Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer.
Randazzo O, Papini F, Mantini G, Gregori A, Parrino B, Liu DSK, Cascioferro S, Carbone D, Peters GJ, Frampton AE, Garajova I, Giovannetti E.
Randazzo O, et al. Among authors: papini f.
Cancers (Basel). 2020 Oct 31;12(11):3206. doi: 10.3390/cancers12113206.
Cancers (Basel). 2020.
PMID: 33142664
Free PMC article.
Item in Clipboard
Cite
Cite